English
Back
Download
Log in to access Online Inquiry
Back to the Top

News

$Tharimmune (THAR.US)$ Tharimmune Announces Results In Phase 1 Clinical Trial Of TH104, Compared Oral Transmucosal Delivery Of TH104 To Injectable Reference Approved Drug Completed
Benzinga· 4 mins ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
1
+0
3
Translate
Report
5127 Views
Comment
Sign in to post a comment
4553
Followers
25
Following
64K
Visitors
Follow
Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks Show More